W. Chai et al. / Tetrahedron Letters 53 (2012) 3514–3517
3517
4. (a) Acree, S. F. Am. Chem. J. 1908, 38, 1–91; (b) Zinner, G.; Deucker, W. Arch.
Pharm. Ber. Dtsch. Pharm. Ges. 1961, 294, 370–372; (c) Park, K.-H.; Cox, L. J.
Tetrahedron Lett. 2002, 43, 3899–3901.
Table 3 (continued)
Entry
R3
Bicyclic Urazole
CH2CH=CH2
Yield %
30
mp (°C)
5. General procedure for synthesis of diphenyl imidodicarbonates: Diphenyl (4-
methoxybenzyl)imidodicarbonate (6e): To a solution of 4-methoxybenzylamine
(0.80 g, 0.76 mL, 5.8 mmol) in dichloromethane (100 mL), triethylamine (2.36 g,
3.25 mL, 23.3 mmol) was added. The solution was cooled to 0 °C, and phenyl
chloroformate (2.27 g, 1.82 mL, 14.5 mmol) and DMAP (0.708 g, 5.8 mmol) were
added. The mixture was heated to 40 °C overnight. The resultant reaction
mixture was washed with water and two times with dilute aq HCl. The organic
layer was dried over Na2SO4 and evaporated in vacuo. This material could be
utilized in the subsequent urazole synthesis as such, or purified by flash
chromatography (silica gel, CH2Cl2). Yield (2.0 g, 90%, mp = 84–85 °C). 1H NMR
(400 MHz, CDCl3): d 7.44 (d, 2H, J = 8 Hz), 7.39 (t, 4H, J = 5 Hz), 7.28 (q, 2H,
N
O
O
6
Allyl
⁄
8f
N
N
Ph
N
O
O
J = 8 Hz), 7.16 (d, 4 H, J = 8 Hz), 6.92 (d, 2H, J = 8 Hz), 5.08 (s, 2H), 3.83 (s, 3H); 13
C
NMR (100 MHz, CDCl3):
d 152.16, 145.08, 143.41, 122.67, 122.37, 122.31,
N
N
7
Ph
36
200–202
8g
121.77, 119.03, 114.18, 133.69, 106.76, 48.00, 42.82; IR (thin film, cmꢀ1): 1745,
1705, 1512, 1487,1435, 1374, 1353, 1320, 1200, 1172, 1157.
6. General procedure for synthesis of urazoles: 4-(40-methoxybenzyl)-1,2,4-
OTBS
triazolidine-3,5-dione
methoxybenzyl)imidodicarbonate (0.502 g, 1.33 mmol) in dichloromethane
(50 mL) at room temperature, anhydrous hydrazine (51 mg, 50 L, 1.58 mmol)
(7e):
To
a
solution
of
diphenyl
(4-
l
CH2CH=CH2
was added over 2 min. The reaction was stirred overnight. The solvent was
removed in vacuo and the residue was stirred with an ether–hexane mixture for
20 min. The precipitated urazole was isolated by filtration. Yield (0.16 g, 55%),
(mp = 189–191 °C). 1H NMR (400 MHz, CDCl3–CD3OD): d 7.34 (d, 2H, J = 8 Hz),
6.83 (d, 2H, J = 8 Hz), 4.59 (s, 2H), 3.76 (s, 3H); 13C NMR (100 MHz, DMSO-d6):
157.28, 153.94, 128.63, 127.79, 112.54, 53.87, 39.55; IR (thin film, cmꢀ1): 1682,
1612, 1514, 1468, 1248.
N
O
O
8h
N
N
8
Allyl
22
⁄
OTBS
7. General procedure for synthesis of dihydropyrazolotriazolediones: Dihydropyrazolo-
4-(40-methoxybenzyl)-1,2,4-triazol-3,5-dione (8e): To
a
solution of 4-
⁄: This product is viscous oil.
methoxybenzyl urazole 7e (0.35 g, 1.58 mmol) in DMF (6 mL), NaH (91 mg,
3.8 mmol) was added. The reaction mixture was stirred for 30 min at room
temperature. Then 1,3-dibromopropane (0.351 g, 177 lL, 1.74 mmol) and NaI
(0.237 g, 1.58 mmol) were added. The reaction mixture was heated to 50 °C for
2 h. The reaction was quenched by water and extracted with ethyl acetate
(50 mL). Then the organic layer was washed with water three times. The organic
layers were dried over Na2SO4 and the solvent was evaporated in vacuo. The
product was further purified by flash chromatography (SiO2, 20% EtOAc/CH2Cl2).
Yield (0.35 g, 84%). 1H NMR (400 MHz, CDCl3): d 7.34 (d, 2H, J = 8 Hz), 6.83 (d,
2H, J = 8 Hz), 4.55 (s, 2H), 3.76 (s, 3H), 3.69 (t, 4H, J = 7.9 Hz), 2.27 (q, 2H,
J = 6.8 Hz); 13C NMR (100 MHz, CDCl3): 159.03, 155.44, 129.70, 127.73, 113.69,
54.96, 44.63, 42.36, 27.77; IR (thin film, cmꢀ1): 1768, 1701, 1612,1513, 1442,
1247.
References and notes
1. (a) Launay, M.; Potin, D.; Maillet, M.J. Bl andine; Nicolai, E. A.; Iwanowicz, E. J.;
Dhar, T. G. M. PCT Int. Appl. WO 2002094186 A2 20021128, 2002, p 44.; (b)
Boatman, P. D.; Urban, J.; Nguyen, M.; Qabar, M.; Kahn, M. Bioorg. Med. Chem.
Lett. 2003, 13, 1445–1449.
2. Mallakpour, S.; Dinari, M. High Perform. Polym. 2010, 22, 314–327.
3. (a) Radl, S. Adv. Heterocycl. Chem. 1996, 67, 119–205; (b) Alberti, M. N.;
Orfanopoulos, M. Org. Lett. 2009, 11, 1659–1662; (c) Alajarin, M.; Bonillo, B.;
Marin-Luna, M.; Sanchez-Andrada, P.; Vidal, A. Eur. J. Org. Chem. 2010, 694–704.